Prospective Analgesic Compound Efficacy (PACE) Study

Summary

A 24-week observational prospective study on the efficacy of topical non-steroidal anti-inflammatory drugs for the relief of pain.

Conditions

• Arthritis
• Tendonitis
• Gout
• Radiculopathy
• Muscle Spasms
• Synovitis
• Migraine
• Headache

Interventions

DRUG

baclofen 2%

compound topical cream

DRUG

Bupivacaine hydrochloride 1%

compound topical cream

DRUG

Cyclobenzaprine hydrochloride 2%

compound topical cream

DRUG

Diclofenac Sodium 3%

compound topical cream

DRUG

Flurbiprofen 10%

compound topical cream

DRUG

Gabapentin 6%

compound topical cream

DRUG

Ketamine 10%

compound topical cream

DRUG

Lidocaine 2%

compound topical cream

DRUG

Prilocaine 2.5%

compound topical cream

DRUG

Meloxicam 0.09%

compound topical cream

DRUG

Sumatriptan 5%

compound topical cream

DRUG

Tizanidine 0.1%

compound topical cream

DRUG

Topiramate 2.5%

compound topical cream

DRUG

Capsaicin, USP 0.0375%

compound topical cream

DRUG

Menthol, NF 5.00 %

compound topical cream

Sponsors & Collaborators

• Express Specialty Pharmacy

  lead OTHER

Principal Investigators

• Kate McLellan, PhD · KM Clinical, Inc.

Eligibility

Min Age

18 Years

Max Age

85 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2015-06-30

Primary Completion

2016-12-31

Completion

2017-02-28